See also this year's filing and all EDGAR filings for this company.
PDF Report 0001396814_2022_Pacira_Biosciences_Inc.pdf
Logs
| warning | Large missing amount for aggregate "Revenues" added to remainder. | industry.us_generic | {'missing_ratio': 4331.264, 'aggregate_val': 541533000, 'exp_sum': 125000, 'exp_to_value': {'remainder_Revenues': 125000}} |
Graph
Absolute values for 0001396814, Pacira Biosciences Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 866,048,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 769,143,000 |
| 2 | PropertyPlantAndEquipmentNet | 188,401,000 |
| 3 | remainder_Assets | 251,761,000 |
| 4 | LiabilitiesCurrent | 521,118,000 |
| 5 | LiabilitiesNoncurrent | 91,699,000 |
| 6 | remainder_Liabilities | 732,128,000 |
| 7 | CostOfGoodsAndServicesSold | 170,922,473 |
| 8 | SellingGeneralAndAdministrativeExpense | 200,801,488 |
| 9 | ResearchAndDevelopmentExpense | 54,021,948 |
| 10 | remainder_Expenses | -112,248,461 |
| 11 | remainder_Revenues | 596,816,325 |
| 12 | remainder_NetIncome | -49,288,997 |
| 13 | remainder_ComprehensiveNetIncome | -132,203 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 2,075,353,000 |
| 1 | Liabilities | 1,344,945,000 |
| 2 | Expenses | 313,497,448 |
| 3 | Revenues | 596,816,325 |
| 4 | StockholdersEquity | 730,408,000 |
| 5 | NetIncome | 234,029,880 |
| 6 | ComprehensiveNetIncome | 233,963,778 |
| 7 | BaseVar | 2,190,016,486 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.07 |
| 9 | EconomicCapitalRatio | 2.36 |
Edgar->Model Mapping
Feature Distribution
Change over Time
